Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
A reversed-phase high-performance liquid chromatographic method for the simultaneous quantitative determination of five HIV protease inhibitors (i.e. indinavir, amprenavir, saquinavir, ritonavir and nelfinavir) in human plasma is described. An aliquot of 500 microl plasma was extracted with 0.5 ml of 0.1 M NH4OH and 5 ml of methyl tert.-butyl ether. After evaporating, the residue was dissolved in eluent mixture of acetonitrile and 50 mM KH2PO4 adjusted to pH 5.6 with 50 mM Na2HPO4 (43:57, v/v). Subsequently, the eluent was washed with hexane. Chromatography was performed using a C18 reversed-phase column. Ultraviolet detection at 215 nm was used. Linearity of the method was obtained in the concentration range of 0.05-20 microg ml(-1) for all five protease inhibitors. Our method is now in use to analyse plasma samples from patients treated with co-administration of HIV protease inhibitors.
Yamada
H
H
Department of Pharmacy, The Research Hospital, The Institute of Medical Science, The University of Tokyo, Japan. hami-tky@umin.ac.jp
Kotaki
H
H
Nakamura
T
T
Iwamoto
A
A
D000328:Adult; D002138:Calibration; D002219:Carbamates; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D005663:Furans; D017320:HIV Protease Inhibitors / Q000032:analysis* / Q000097:blood; D006801:Humans; D019469:Indinavir / Q000032:analysis* / Q000097:blood; D008297:Male; D019888:Nelfinavir / Q000032:analysis* / Q000097:blood; D019438:Ritonavir / Q000032:analysis* / Q000097:blood; D019258:Saquinavir / Q000032:analysis* / Q000097:blood; D013449:Sulfonamides / Q000032:analysis* / Q000097:blood
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir; D019469:Indinavir; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir